1. Project
  2. NTX1088
  3. Organisations

First-in-class anti-PVR mAb NTX1088 - a novel oncology drug that unlocks the power of human immune system and revolutionizes cancer care

Full project page

Organisations map overview


Powered by Chris Decubber BV